Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine

Journal of Neuroscience Research

Volumn 78, Issue 2, 2004, Pages 289-296

  Avale, María Elena ^a   Nemirovsky, Sergio Iván ^a   Raisman Vozari, Rita ^b   Rubinstein, Marcelo ^a,c,d  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CENTRO DE ESTUDIOS CIENTÍFICOS CECS   (Chile)

^d INGEBl CONlCET   (Argentina)

Author keywords

6 hydroxydopamine; Dopamine; p chlorophenylalanine; Serotonin

Indexed keywords

AMPHETAMINE; CITALOPRAM; FENCLONINE; OXIDOPAMINE; PSYCHOSTIMULANT AGENT; SEROTONIN; SEROTONIN TRANSPORTER; TRITIUM; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; FEMALE; GENE MUTATION; HYPERACTIVITY; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

AMPHETAMINE; ANIMALS; ANIMALS, NEWBORN; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FENCLONINE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; OXIDOPAMINE; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN HYDROXYLASE;

EID: 4744368689     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20245     Document Type: Article

References (38)

1. Archer T, Danysz W, Fredriksson A, Jonsson G, Luthman J, Sundstrom E, Teiling A. 1988. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning. Pharmacol Biochem Behav 31:357-364.
2. Avale ME, Falzone TL, Gelman DM, Low MJ, Grandy DK, Rubinstein M. 2004. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperaetivity disorder. Mol Psychiatry 9:718-726.
3. 2A/2C agonism. J Pharmacol Exp Ther (in press).
4. Björklund A, Wiklund L, Descarries L. 1981. Regeneration and plasticity of central serotoninergic neurons: a review. J Physiol (Paris) 77:247-255.
5. Brocco M, Dekeyne A, Veiga S, Girardon S, Millan MJ. 2002. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Pharmacol Biochem Behav 71:667-680.
6. Chin LG, Ni DR, Cheng FC, Ho YP, Kuo JS. 1999. Intrastriatal injection of 5,7-dihydroxytryptamine decreased 5-HT levels in the striatum and suppressed locomotor activity in C57BL/6 mice. Neurochem Res 24:719-722.
7. Chiavegatto S, Dawson VL, Mamounas LA, Koliatsos VE, Dawson TM, Nelson RJ. 2001. Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. Proc Natl Acad Sci USA 98:1277-1281.
8. Cunningham KA, Bradberry CW, Chang AS, Reith ME. 1996. The role of serotonin in the actions of psychostimulants: molecular and pharmacological analyses. Behav Brain Res 73:93-102.
9. Davids E, Zhang K, Kula NS, Tarazi FI, Baldessarini RJ. 2002. Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J Pharmacol Exp Ther 301:1097-1102.
10. Descarries L, Soghomonian JJ, Garcia S, Doucet G, Bruno JP. 1992. Ultrastructural analysis of the serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxydopamine. Brain Res 569:1-13.
11. Deumens R, Blokland A, Prickaerts J. 2002. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175:303-317.
12. Ferguson SA. 2001. A review of rodent models of ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX, editors. Stimulant drugs and ADHD: basic and clinical neuroscience. New York: Oxford University Press, p 209-220.
13. Franklin KBJ, Paxinos G. 2001. The mouse brain in stereotaxic coordinates. San Diego, CA: Academic Press.
14. Gainetdinov RR, Wetsel WC, Jones SR, Levin FD, Jaber M, Caron MG. 1999. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401.
15. Gately PF, Poon SL, Segal DS, Geyer MA. 1985. Depletion of brain serotonin by 5,7-dihydroxytryptamine alters the response to amphetamine and the habituation of locomotor activity in rats. Psychopharmcology (Berl) 87:400-405.
16. Gelman DM, Noain D, Avale ME, Otero V, Low MJ, Rubinstein M. 2003. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons. Genesis 36:196-202.
17. Geyer MA. 1996. Serotonergic functions in arousal and motor activity. Behav Brain Res 73:31-35.
18. Heffner TG, Seiden LS. 1982. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine. Brain Res 244:81-90.
19. Jacobowitz DM, Abbot LC. 1998. Chemoarchitectonic atlas of the developing mouse brain. Boca Raton. FL: CRC Press LLC.
20. Jacobs BL, Fornal CA. 1997. Serotonin and motor activity. Curr Opin Neurobiol 7:820-825.
21. Kent L, Doerry U, Hardy E, Parmar R, Gingell K, Hawi Z, Kirley A, Lowe N, Fitzgerald M, Gill M, Craddock N. 2002. Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Mol Psychiatry 7:908-912.
22. Kostrzewa RM, Reader TA, Descarries L. 1998. Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain. J Neurochem 70:889-898.
23. Luthman J, Fredriksson A, Plaznik A, Archer T. 1991. Ketanserin and mianserin treatment reverses by hyperactivity in neonatally dopamine-lesioned rats. J Psychopharmacol 5:418-421.
24. Luthman J, Lindqvist E, Ogren SO. 1995. Hyperactivity in neonatally dopamine-lesioned rats requires residual activity in mesolimbic dopamine neurons. Pharmacol Biochem Behav 51:159-163.
25. Miller FE, Heffner TG, Kotake C, Seiden LS. 1981. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion. Brain Res 229:123-132.
26. Molina-Holgado E, Dewar KM, Descarries L, Reader TA. 1994. Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine. J Pharmacol Exp Ther 270:713-721.
27. Murer MG, Dziewczapolski G, Menalled LB, Garcia MC, Agid Y, Gershanik O, Raisman-Vozari R. 1998. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions. Ann Neurol 43:561-575.
28. Oades RD. 2002. Dopamine may be "hyper" with respect to noradrenaline metabolism, but "hypo" with respect to serotonin metabolism in children with attention-deficit hyperactivity disorder. Behav Brain Res 130:97-102.
29. Quist JF, Barr CL, Schachar R, Roberts W, Malone M, Tannock R, Basile VS, Beitchman J, Kennedy JL. 2003. The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder. Mol Psychiatry 8:98-102.
30. Rothman RB, Baumann MH. 2003. Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479:23-40.
31. Sanders-Bush E, Gallager DA, Sulser F. 1974. On the mechanism of brain 5-hydroxytryptamine depletion by p-chloroamphetamine and related drugs and the specificity of their action. Adv Biochem Psychopharmacol 10:185-194.
32. Shaywitz BA, Klopper JH, Yager RD, Gordon JW. 1976a. Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine. Nature 261:153-155.
33. Shaywitz BA, Yager RD, Klopper JH. 1976b. Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 191:305-308.
34. Snyder AM, Zigmond MJ, Lund RD. 1986. Sprouting of serotoninergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study. J Comp Neurol 245:274-281.
35. Takahashi H, Takada Y, Nagai N, Urano T, Takada A. 2000. Serotonergic neurons projecting to hippocampus activate locomotion. Brain Res 869:194-202.
36. Zhang K, Davids E, Tarazi FI, Baldessarini RJ. 2002. Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity. Brain Res Dev Brain Res 137:135-138.
37. Zigmond MJ, Stricker EM. 1973. Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. Science 182:717-720.
38. Zigmond MJ, Stricker EM. 1985. Adaptive properties of monoaminergic neurons and their functional implications. In: Lajtha A, editor. Handbook of neurochemistry, Vol 9. New York: Plenum Press, p 87-102.